Andersen-Tawil syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
*Patients with Andersen-Tawil syndrome (ATS) may experience weakness when the potassium levels in the blood drops to low which suggests the name  hypokalemic periodic paralysis.<ref name="NguyenPieper2013">{{cite journal|last1=Nguyen|first1=Hoai-Linh|last2=Pieper|first2=Gerard H.|last3=Wilders|first3=Ronald|title=Andersen–Tawil syndrome: Clinical and molecular aspects|journal=International Journal of Cardiology|volume=170|issue=1|year=2013|pages=1–16|issn=01675273|doi=10.1016/j.ijcard.2013.10.010}}</ref><ref name="pmid24383070">{{cite journal| author=Nguyen HL, Pieper GH, Wilders R| title=Andersen-Tawil syndrome: clinical and molecular aspects. | journal=Int J Cardiol | year= 2013 | volume= 170 | issue= 1 | pages= 1-16 | pmid=24383070 | doi=10.1016/j.ijcard.2013.10.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24383070  }}</ref>
*Patients with Andersen-Tawil syndrome (ATS) may experience weakness when the potassium levels in the blood drops to low which suggests the name  hypokalemic periodic paralysis.<ref name="NguyenPieper2013">{{cite journal|last1=Nguyen|first1=Hoai-Linh|last2=Pieper|first2=Gerard H.|last3=Wilders|first3=Ronald|title=Andersen–Tawil syndrome: Clinical and molecular aspects|journal=International Journal of Cardiology|volume=170|issue=1|year=2013|pages=1–16|issn=01675273|doi=10.1016/j.ijcard.2013.10.010}}</ref><ref name="pmid24383070">{{cite journal| author=Nguyen HL, Pieper GH, Wilders R| title=Andersen-Tawil syndrome: clinical and molecular aspects. | journal=Int J Cardiol | year= 2013 | volume= 170 | issue= 1 | pages= 1-16 | pmid=24383070 | doi=10.1016/j.ijcard.2013.10.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24383070  }}</ref>
*Weakness may also occurs in patients with Andersen-Tawil syndrome (ATS) when the potassium levels are even normal but the weakness may be triggered by exercise, cold, or even sometimes menstruation.
*Weakness may also occurs in patients with Andersen-Tawil syndrome (ATS) when the potassium levels are even normal but the weakness may be triggered by exercise, cold, or even sometimes menstruation.
*Thyroid hormones such as thyroid-stimulating hormone (TSH), T4, and T3  levels should be checked due to thyrotoxic periodic paralysis can also present with muscle weakness  and paralysis.
*Thyroid hormones such as thyroid-stimulating hormone (TSH), T4, and T3  levels should be checked due to thyrotoxic periodic paralysis can also present with muscle weakness  and paralysis.<ref name="pmid20074522">{{cite journal| author=Ryan DP, da Silva MR, Soong TW, Fontaine B, Donaldson MR, Kung AW | display-authors=etal| title=Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. | journal=Cell | year= 2010 | volume= 140 | issue= 1 | pages= 88-98 | pmid=20074522 | doi=10.1016/j.cell.2009.12.024 | pmc=2885139 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20074522  }}</ref>


==References==
==References==

Revision as of 16:10, 11 February 2020

Andersen-Tawil syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Andersen-Tawil syndrome from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Andersen-Tawil syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Andersen-Tawil syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Andersen-Tawil syndrome laboratory findings

CDC on Andersen-Tawil syndrome laboratory findings

Andersen-Tawil syndrome laboratory findings in the news

Blogs on Andersen-Tawil syndrome laboratory findings

Directions to Hospitals Treating Andersen-Tawil syndrome

Risk calculators and risk factors for Andersen-Tawil syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Laboratory findings consistent with the diagnosis of Andersen-Tawil syndrome (ATS) include serum potassium levels. Some patients with Andersen-Tawil syndrome (ATS) may have elevated/reduced concentration of serum potassium levels, which is usually suggestive of Andersen-Tawil syndrome (ATS).

Laboratory Findings

  • There are no diagnostic laboratory findings associated with Andersen-Tawil syndrome (ATS).
  • An elevated/reduced concentration of serum potassium levels is consistent in Andersen-Tawil syndrome (ATS).[1]
  • Patients with Andersen-Tawil syndrome (ATS) may experience weakness when the potassium levels in the blood drops to low which suggests the name hypokalemic periodic paralysis.[2][3]
  • Weakness may also occurs in patients with Andersen-Tawil syndrome (ATS) when the potassium levels are even normal but the weakness may be triggered by exercise, cold, or even sometimes menstruation.
  • Thyroid hormones such as thyroid-stimulating hormone (TSH), T4, and T3 levels should be checked due to thyrotoxic periodic paralysis can also present with muscle weakness and paralysis.[4]

References

  1. Sansone V, Tawil R (2007). "Management and treatment of Andersen-Tawil syndrome (ATS)". Neurotherapeutics. 4 (2): 233–7. doi:10.1016/j.nurt.2007.01.005. PMID 17395133.
  2. Nguyen, Hoai-Linh; Pieper, Gerard H.; Wilders, Ronald (2013). "Andersen–Tawil syndrome: Clinical and molecular aspects". International Journal of Cardiology. 170 (1): 1–16. doi:10.1016/j.ijcard.2013.10.010. ISSN 0167-5273.
  3. Nguyen HL, Pieper GH, Wilders R (2013). "Andersen-Tawil syndrome: clinical and molecular aspects". Int J Cardiol. 170 (1): 1–16. doi:10.1016/j.ijcard.2013.10.010. PMID 24383070.
  4. Ryan DP, da Silva MR, Soong TW, Fontaine B, Donaldson MR, Kung AW; et al. (2010). "Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis". Cell. 140 (1): 88–98. doi:10.1016/j.cell.2009.12.024. PMC 2885139. PMID 20074522.


Template:WikiDoc Sources